NATCO Pharma Limited (BOM:524816)
India
· Delayed Price · Currency is INR 797.70
-24.70 (-3.00%)
At close: Mar 28, 2025
NATCO Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 27, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Market Capitalization | 144,461 | 170,522 | 102,795 | 138,013 | 150,529 | 92,044 | Upgrade
|
| Market Cap Growth | 70.99% | 65.89% | -25.52% | -8.31% | 63.54% | -12.17% | Upgrade
|
| Enterprise Value | 121,980 | 160,841 | 93,605 | 133,992 | 144,005 | 84,751 | Upgrade
|
| Last Close Price | 806.35 | 946.97 | 554.85 | 738.82 | 800.78 | 487.49 | Upgrade
|
| PE Ratio | 7.75 | 12.28 | 14.37 | 81.18 | 34.14 | 19.98 | Upgrade
|
| PS Ratio | 5.81 | 4.26 | 3.80 | 7.09 | 7.32 | 4.81 | Upgrade
|
| PB Ratio | 3.47 | 2.91 | 2.11 | 3.24 | 3.65 | 2.43 | Upgrade
|
| P/TBV Ratio | 3.60 | 3.01 | 2.19 | 3.34 | 3.66 | 2.44 | Upgrade
|
| P/FCF Ratio | 19.55 | 14.63 | - | 340.56 | 149.42 | Upgrade
| |
| P/OCF Ratio | 14.07 | 12.11 | 296.80 | 50.38 | 22.06 | Upgrade
| |
| EV/Sales Ratio | 2.85 | 4.02 | 3.46 | 6.89 | 7.00 | 4.43 | Upgrade
|
| EV/EBITDA Ratio | 5.65 | 9.19 | 9.68 | 51.54 | 23.74 | 14.56 | Upgrade
|
| EV/EBIT Ratio | 6.23 | 10.24 | 11.56 | 108.58 | 29.19 | 17.45 | Upgrade
|
| EV/FCF Ratio | 18.44 | 13.32 | - | 325.80 | 137.58 | Upgrade
| |
| Debt / Equity Ratio | 0.03 | 0.07 | 0.04 | 0.10 | 0.07 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | 0.22 | 0.18 | 1.64 | 0.47 | 0.57 | Upgrade
|
| Debt / FCF Ratio | - | 0.44 | 0.25 | - | 6.42 | 5.35 | Upgrade
|
| Asset Turnover | - | 0.64 | 0.50 | 0.39 | 0.44 | 0.43 | Upgrade
|
| Inventory Turnover | - | 0.94 | 0.78 | 0.66 | 0.66 | 0.63 | Upgrade
|
| Quick Ratio | - | 2.73 | 2.47 | 2.02 | 2.48 | 2.23 | Upgrade
|
| Current Ratio | - | 4.14 | 4.39 | 3.50 | 4.46 | 3.39 | Upgrade
|
| Return on Equity (ROE) | - | 25.88% | 15.66% | 4.05% | 11.19% | 12.59% | Upgrade
|
| Return on Assets (ROA) | - | 15.63% | 9.40% | 1.56% | 6.57% | 6.83% | Upgrade
|
| Return on Capital (ROIC) | 18.97% | 17.39% | 10.39% | 1.69% | 7.24% | 7.60% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 26.50% | 16.30% | 2.80% | 11.60% | 12.40% | Upgrade
|
| Earnings Yield | 12.91% | 8.14% | 6.96% | 1.23% | 2.93% | 5.01% | Upgrade
|
| FCF Yield | 5.12% | 6.84% | -1.35% | 0.29% | 0.67% | Upgrade
| |
| Dividend Yield | 0.75% | 1.00% | 0.99% | 0.61% | 0.66% | 1.39% | Upgrade
|
| Payout Ratio | 0.00% | 12.30% | 14.04% | 48.35% | 25.83% | 27.65% | Upgrade
|
| Buyback Yield / Dilution | 0.71% | 1.67% | -0.08% | 0.04% | -0.02% | 1.26% | Upgrade
|
| Total Shareholder Return | 1.46% | 2.68% | 0.91% | 0.65% | 0.64% | 2.64% | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.